The global synthetic biology market size was estimated at USD 16.22 billion in 2024 and is projected to grow at a CAGR of 17.30% from 2025 to 2030. Emerging applications of synthetic biology in areas such as multiplexed diagnostics, cellular recording, and therapeutic genome editing are projected to lead to a substantial rise in demand for synthetic products over the forecast period. Furthermore, the integration of synthetic biology-based products and techniques into sectors such as energy and chemicals are likely to boost the overall market growth. As these applications diversify further, the utility of synthetic biology is expected to increase, promoting further adoption and market growth.

The COVID-19 pandemic has significantly increased the use of synthetic biology products over the past two years. Numerous leading pharmaceutical and biotechnology companies, along with key players in the synthetic biology field, have ramped up their research efforts worldwide, employing innovative techniques to produce test kits, therapies, and vaccines for COVID-19. According to a study by the European Parliament, synthetic biology is recognized as a developing technology with potential applications in combating COVID-19 infections. In addition, the U.S. National Institutes of Health has emphasized synthetic biology as a tool to expedite vaccine development.

Gather more insights about the market drivers, restrains and growth of the Global synthetic biology market

Synthetic Biology Market Segments Highlights:

• The enzymes segment dominated the market in 2024 with a share of 36.79%. Enzymes play an essential role in various biotechnological processes, including DNA manipulation, protein engineering, and metabolic pathway construction.
• The cloning technologies kits segment is expected to experience the fastest CAGR of 18.43% over the forecast period.
• The PCR segment accounted for the largest market share of 30.07% in 2024, and this trend is expected to persist in the coming years. Polymerase Chain Reaction (PCR) has become a pivotal technology for the detection and analysis of specific gene sequences.
• The genome editing technology is projected to experience substantial growth at a significant CAGR from 2025 to 2030.
• The healthcare segment dominated the market in 2024 due to its critical role in developing innovative therapies and diagnostics.
• The non-healthcare segment is projected to grow at a significant CAGR from 2025 to 2030 due to increasing applications in industries like agriculture, energy, and materials. Innovations in synthetic biology enable the development of biofuels, sustainable bioplastics, and crop enhancement solutions, driving demand for eco-friendly alternatives.
• The biotechnology and pharmaceutical companies segment captured the largest revenue share of 54.92% in 2024 due to their pivotal role in advancing medical innovations and therapeutic solutions.
• The academic and research institutes segment is anticipated to grow at a significant CAGR from 2025 to 2030 due to their essential role in driving innovation and discovery.
• North America synthetic biology market held the largest market share of 41.98% in 2024, driven by strong investment from both public and private sectors, including significant funding from venture capital and government initiatives.

Browse through Grand View Research's Biotechnology Industry Research Reports.

• Cell Culture Vessels Market: The global cell culture vessels market size was valued at USD 3.77 billion in 2023 and is projected to witness a CAGR of 14.8% from 2024 to 2030.
• DNA Diagnostics Market: The global DNA diagnostics market size was estimated at USD 10.64 billion in 2023 and is projected to grow at a CAGR of 4.51% from 2024 to 2030.

Synthetic Biology Market Segmentation

Grand View Research has segmented the global synthetic biology market based on product, technology, application, end use, and region

Synthetic Biology Product Outlook (Revenue, USD Million, 2018 - 2030)

• Oligonucleotide/Oligo Pools and Synthetic DNA
• Enzymes
• Cloning Technologies Kits
• Xeno-Nucleic Acids
• Chassis Organism

Synthetic Biology Technology Outlook (Revenue, USD Million, 2018 - 2030)

• NGS Technology
• PCR Technology
• Genome Editing Technology
• Bioprocessing Technology
• Other Technologies

Synthetic Biology Application Outlook (Revenue, USD Million, 2018 - 2030)

• Healthcare
  • Clinical
    • Bio/Pharmaceuticals
    • Diagnostics
  • Non-Clinical
• Non-healthcare
  • Biotech Crops
  • Specialty Chemicals
  • Bio-fuels
  • Others

Synthetic Biology End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Biotechnology and Pharmaceutical companies
• Academic and Research Institutes
• Others

Synthetic Biology Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Order a free sample PDF of the Synthetic Biology Market Intelligence Study, published by Grand View Research.